Latest Laboratory Services News

Page 1 of 3
ALS has delivered a sharp lift in underlying earnings and dividend growth, powered by a 30.4% organic surge in Minerals. But the result also exposes a weaker side of the portfolio, with Life Sciences growth expectations cut to about 3% for FY27.
Victor Sage
Victor Sage
23 Nov 2026
Charles River Laboratories delivered a second consecutive quarter of organic revenue growth and raised its 2026 outlook, despite reported revenue falling after divestitures. The quarter’s sharp GAAP earnings increase was heavily amplified by a US$245.6 million tax reserve reversal.
Ada Torres
Ada Torres
4 Nov 2026
Mount Ridley Mines says its patent-pending Selectro process recovered 91.9% of aluminium and 96.7% of iron from a third-party bauxite sample at below 100°C. The test produced a small, pH-neutral silica-rich residue instead of conventional red mud, but product purification, economics and scale-up remain unproven.
Victor Sage
Victor Sage
15 Oct 2026
Forrestania Resources has secured a framework to purchase and process up to 2 million tonnes of third-party ore while locking in key laboratory, haulage and reagent arrangements for its Lake Johnston and Edna May hubs. The agreements strengthen restart preparation, although financial terms, margins and delivery timing remain undisclosed.
Maxwell Dee
Maxwell Dee
9 Sept 2026
Stavely Minerals has confirmed a significant blind gold-silver discovery beneath basalt cover at its Freddy’s Find Prospect, with diamond drilling revealing higher-grade mineralisation at depth. Further reconnaissance drilling is planned to expand the target and test adjacent porphyry prospects.
Maxwell Dee
Maxwell Dee
19 Aug 2026
ALS Limited reported record FY26 financial results driven by strong growth in Minerals and Industrial Materials, while advancing its digital transformation through the Lab of the Future initiative. Leadership changes and a strategic portfolio review underpin its disciplined capital allocation approach.
Victor Sage
Victor Sage
28 July 2026
Microba Life Sciences is targeting a $6 million capital raise through a $1 million Securities Purchase Plan and a $5 million Placement, both subject to shareholder approval. The funds aim to accelerate diagnostics growth and develop a new testing product.
Ada Torres
Ada Torres
19 June 2026
Triton Minerals advances the sale of a majority stake in its Mozambique graphite assets pending government approval, while assay results from its AuCu Gold-Copper drilling program remain delayed due to lab backlogs.
Maxwell Dee
Maxwell Dee
19 Mar 2026
Sonic Healthcare has reported a robust half-year performance, with revenue climbing 16.6% to A$5.45 billion and net profit rising 10.9%, underpinned by organic growth and key acquisitions. The company maintains its full-year guidance amid ongoing US business rationalisation.
Ada Torres
Ada Torres
19 Feb 2026
Microba Life Sciences reports robust year-on-year growth in microbiome testing volumes and revenue, advancing towards regional break-even in Australia and the UK while progressing its therapeutic pipeline.
Ada Torres
Ada Torres
29 Jan 2026
Rhythm Biosciences has begun commercialising ColoSTAT®, its blood-based colorectal cancer diagnostic test, following an updated ISO15189, 2022 accreditation. The test offers a new option for symptomatic patients where stool-based screening is unsuitable.
Ada Torres
Ada Torres
12 Dec 2025
Marmota Limited is progressing its scoping study for the Gawler Gold Project, aiming to establish a heap leach facility processing 1 million tonnes annually over seven years. Completion is targeted by March 2026, with key technical workstreams underway.
Maxwell Dee
Maxwell Dee
18 Nov 2025

Browse the archive

Full archive